H

Heron Therapeutics
D

HRTX

1.61000
USD
0.04
(2.55%)
Pre Open
Volume
25
EPS
-2
Div Yield
-
P/E
-10
Market Cap
244,872,808
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.320
    (1.90%)
    17.200 USD
    ALNY
    ALNY
    -3.355
    (-1.37%)
    242.150 USD
    B
    BLUE
    -0.87500
    (-10.31%)
    7.61500 USD
    B
    BMRN
    0.560
    (0.85%)
    66.240 USD
    C
    CRBP
    0.180
    (1.39%)
    13.140 USD
    E
    EXEL
    0.190
    (0.57%)
    33.470 USD
    GILD
    GILD
    0.800
    (0.86%)
    93.370 USD
    I
    INCY
    0.950
    (1.38%)
    69.860 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    S
    SRPT
    1.570
    (1.32%)
    120.540 USD
    More
News

Title: Heron Therapeutics

Sector: Healthcare
Industry: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.